Concepedia

Marcus Hompesch

MH

Statistics

Publications

49

Citations

2.5K

H-Index

29

Active since

2004

Affiliations

Profil Institute for Clinical Research(Current)

Precision Research Institute

Profil Institute for Metabolic Research

Hanmi Pharmaceutical (South Korea)

Sanofi (Canada)

Marcus Hompesch is an author at Profil Institute for Clinical Research specializing in pharmacology, diabetes mellitus, and medicine.

Publications per year

2004–2021

49

Publications

49

Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes

Ralph A. DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula et al. · Diabetes Care · 2013 · 288 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin

Damayanthi Devineni, Linda Morrow, Marcus Hompesch et al. · Diabetes Obesity and Metabolism · 2012 · 221 citations

Medicine, Pharmacokinetics, Pharmacology +17

Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes

Andrés Digenio, Richard L. Dunbar, Veronica Alexander et al. · Diabetes Care · 2016 · 168 citations

Medicine, Pharmacology, Pharmacotherapy +17

Five Weeks of Treatment with the GLP-1 Analogue Liraglutide Improves Glycaemic Control and Lowers Body weight in Subjects with Type 2 Diabetes

M. Nauck, Marcus Hompesch, R. Filipczak et al. · Experimental and Clinical Endocrinology & Diabetes · 2006 · 143 citations

Medicine, Pharmacology, Pharmacotherapy +16

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects

Amparo de la Peña, Matthew C. Riddle, Linda Morrow et al. · Diabetes Care · 2011 · 122 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

1–5 of 49